Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 178Congress 0Executive branch 0Insiders 178
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

TRDA · $15K+ · 178 trades

Trades
178
Buys 0 · Sells 178
People
20
Stocks
1
Disclosed value
$56M
range midpoints · Congress & executive
Filed late
13
  1. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$159Kdisclosed Aug 26 · filed 2 days after the trade
  2. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
  3. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$159Kdisclosed Aug 26 · filed 2 days after the trade
  4. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$159Kdisclosed Aug 26 · filed 2 days after the trade
  5. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
  6. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
  7. ▼ SELLKush Parmar DirectorTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  8. ▼ SELLAndrew J. Schwab 10% ownerTRDA Entrada Therapeutics, Inc.$358Kdisclosed Aug 10 · filed 3 days after the trade
  9. ▼ SELL5AM Partners V, LLC 10% ownerTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  10. ▼ SELL5AM Ventures V, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  11. ▼ SELLAndrew J. Schwab 10% ownerTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  12. ▼ SELL5AM Opportunities I (GP), LLC 10% ownerTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  13. ▼ SELLKush Parmar DirectorTRDA Entrada Therapeutics, Inc.$358Kdisclosed Aug 10 · filed 3 days after the trade
  14. ▼ SELL5AM Ventures V, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$358Kdisclosed Aug 10 · filed 3 days after the trade
  15. ▼ SELL5AM Opportunities I, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$358Kdisclosed Aug 10 · filed 3 days after the trade
  16. ▼ SELL5AM Opportunities I, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  17. ▼ SELL5AM Partners V, LLC 10% ownerTRDA Entrada Therapeutics, Inc.$358Kdisclosed Aug 10 · filed 3 days after the trade
  18. ▼ SELL5AM Opportunities I (GP), LLC 10% ownerTRDA Entrada Therapeutics, Inc.$358Kdisclosed Aug 10 · filed 3 days after the trade
  19. ▼ SELLKush Parmar DirectorTRDA Entrada Therapeutics, Inc.$647Kdisclosed Aug 10 · filed the same day
  20. ▼ SELLScott M Rocklage 10% ownerTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  21. ▼ SELLScott M Rocklage 10% ownerTRDA Entrada Therapeutics, Inc.$358Kdisclosed Aug 10 · filed 3 days after the trade
  22. ▼ SELL5AM Partners V, LLC 10% ownerTRDA Entrada Therapeutics, Inc.$795Kdisclosed Aug 3 · filed 4 days after the trade
  23. ▼ SELL5AM Ventures V, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$795Kdisclosed Aug 3 · filed 4 days after the trade
  24. ▼ SELLAndrew J. Schwab 10% ownerTRDA Entrada Therapeutics, Inc.$795Kdisclosed Aug 3 · filed 4 days after the trade
  25. ▼ SELLScott M Rocklage 10% ownerTRDA Entrada Therapeutics, Inc.$795Kdisclosed Aug 3 · filed 4 days after the trade